The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AstraZeneca swings to profit; Unilever volumes fall

Thu, 09th Feb 2023 07:55

(Alliance News) - Stocks in London were called to open higher on Thursday, as investors in Europe kept their cool, despite hawkish US central bankers and a weak finish on Wall Street.

Sentiment in New York was undermined by the latest comments by a Federal Reserve official, seeming to indicated high interest rates could persist for "a few years".

In comments reported by Bloomberg, Fed Vice Chair John Williams advocated for a "sufficiently restrictive stance of policy", adding that interest rates were "barely into restrictive territory".

"We're going to need to maintain that for a few years to make sure we get inflation to 2%, and then eventually over time we'll get interest rates presumably back to more normal levels," Williams said.

Fed Governor Christopher Waller added: "It might be a long fight, with interest rates higher for longer than some are currently expecting."

Meanwhile, Minneapolis Fed President Neel Kashkari warned there was "not yet much evidence, in my judgment, that the rate hikes that we've done so far are having much effect on the labour market".

"We need to bring the labour market into balance, so that tells me we need to do more."

"So, the message is clear. The Fed is not done yet. This means that the rate hikes will continue, and that will continue pressuring the US yields higher as well," said Swissquote Bank's Ipek Ozkardeskaya.

Meanwhile, Europe's largest economy saw inflation speed up slightly at the beginning of the year, according to preliminary figures released early Thursday.

Destatis said consumer prices in Germany rose 1.0% in January from the month before, reversing a 0.8% monthly decline in December. Annual inflation ticked up to 8.7% from 8.6% at the end of 2022.

On a harmonised basis - which allows for EU-wide comparison - prices rose 0.5% on a monthly basis, compared to a 1.2% fall in December. Harmonised annual inflation eased to 9.2% from 9.6% a month before, however.

In early corporate news, AstraZeneca saw double-digit annual sales growth in 2022, despite a weaker fourth quarter, while Unilever said a fall in annual sales volumes is likely to persist into the first half of 2023.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 22.7 points, 0.3%, at 7,907.87

----------

Hang Seng: up 1.5% at 21,592.60

Nikkei 225: closed down 0.1% at 27,584.35

S&P/ASX 200: closed down 0.5% at 7,490.30

----------

DJIA: closed down 207.68 points, or 0.6%, at 33,949.01

S&P 500: closed down 46.14 points, or 1.1%, at 4,117.86

Nasdaq Composite: closed down 203.27 points, or 1.7%, at 11,910.52

----------

EUR: up at USD1.0738 (USD1.0734)

GBP: up at USD1.2097 (USD1.2084)

USD: flat at JPY131.28 (JPY131.29)

GOLD: up at USD1,880.75 per ounce (USD1,878.10)

OIL (Brent): up at USD85.17 a barrel (USD84.01)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

08:30 EST US unemployment insurance weekly claims report

08:30 EST US weekly export sales

16:30 EST US Foreign Central Bank holdings

16:30 EST US federal discount window borrowings

----------

UK house prices are starting to reflect the shift in demand in the market, according to surveyors. Agreed sales, house prices and new instructions to sell homes remained on a downward trend in January, the Royal Institution of Chartered Surveyors said. Property professionals' expectations suggest this picture is likely to remain in place for a while longer as the market adjusts to higher interest rates, Rics' report added. A net balance of 47% of surveyors reported seeing a fall rather than an increase in new buyer inquiries, deteriorating from a balance of 40% who saw this the previous month.

----------

Civil servants working in the UK government's biggest department start 20 days of strikes as part of the long-running dispute over pay, jobs, pensions and conditions. Members of the Public & Commercial Services union working for the Department for Work & Pensions in a number of jobcentres and other offices will be involved in the action. The PCS said around 500 of its members in Bolton and Stockport and 170 in jobcentres in Liverpool will strike in the coming weeks.

----------

BROKER RATING CHANGES

----------

Berenberg starts Ashtead Technology with 'buy' - price target 405 pence

----------

Barclays starts Ithaca Energy with 'underweight' - price target 140 pence

----------

HSBC cuts Hiscox to 'hold' (buy) - price target 1,250 (1,150) pence

----------

COMPANIES - FTSE 100

----------

British American Tobacco said revenue rose 7.7% in 2022, reaching GBP27.66 billion from GBP25.68 billion, with GBP2.89 billion coming from New Categories, which saw 41% growth. Pretax profit edged up to GBP9.32 billion from GBP9.16 billion. Looking ahead to 2023, BAT expects global tobacco industry volume to fall by around 2%. The Dunhill cigarette maker expects 3% to 5% organic constant currency revenue growth, with strong growth expected in New Categories, which includes heated and vaping products. It expects mid-single figure constant currency adjusted earnings per share growth, which will be weighted towards the second half. CEO Jack Bowles expects the macro-economic environment to "remain challenging", but is confident of delivering "long-term sustainable value" for BAT's shareholders.

----------

AstraZeneca said total revenue in 2022 rose by 19% to USD44.35 billion from USD37.42 billion a year before, or by 24% at constant currency. Growth came from all therapy areas, as well as the addition of Alexion. Astra swung to a pretax profit of USD2.50 billion from a loss of USD265 million, while core earnings per share jumped 26% to USD6.66. The pharmaceutical maker saw a weaker fourth quarter, however, as revenue fell by 7% to USD11.21 billion and core EPS fell by 17% to USD1.38. The lower revenue in the quarter was partly due to the decline in Vaxzevria, Astra said. Revenue excluding Vaxzevria rose 17%. Looking ahead, Astra expects revenue in 2023 to grow at low-to-mid single-digit percentages at constant currency, or by low double-digit percentages excluding Covid-19 medicines. Core EPS is expected to see high single-digit to low double-digit growth.

----------

Consumer goods firm Unilever said annual turnover rose 15% year-on-year to EUR60.07 billion from EUR52.44 billion, as pretax profit rose 21% to EUR10.34 billion from EUR8.56 billion. Underlying sales growth was 9.0%, driven by price growth, given that volumes fell 2.1%. In 2023, Unilever expects to deliver strong underlying sales growth and improving volume performance. It said net material inflation in the first half is expected to be around EUR1.5 billion, but will be "significantly lower" in the second half. It expects underlying price growth to remain high and volumes to fall in the first half, but said it is "too early to say" whether volumes will see positive growth in the second half. Unilever expects 2023 underlying sales growth to be at least in the upper half of a 3% to 5% range. "Despite sharp rises in material costs, we have prioritised stepping up our brand and marketing investment," said CEO Alan Jope.

----------

COMPANIES - FTSE 250

----------

Watches of Switzerland reported double-digit growth in its financial third quarter ended January 29, as revenue rose 17% year-on-year to GBP407 million from GBP348 million. This was driven by luxury watches, "where demand continues to exceed supply". The firm remains confident of delivery long-term growth. For the whole of financial 2023, Watches expects to bring in revenue of GBP1.50 billion to GBP1.55 billion, with adjusted earnings before interest and tax to be between GBP163 million to GBP175 million. The guidance is on a pre-IFRS 16 basis, with a constant exchange rate applied to the fourth quarter. CEO Brian Duffy reports the firm's expansion into Europe is seeing "positive" early trading.

----------

OTHER COMPANIES

----------

Japan's Toyota Motor left its annual forecasts unchanged despite ongoing disruption from the global chip shortage. The world's top-selling automaker, which reshuffled its executive line-up last month, is still suffering production setbacks caused by the semiconductor shortage along with other industry players. But it said it still expects net profit of JPY2.36 trillion, about USD18 billion, in the 12 months to March 2023, down 17% on-year. Toyota logged a third-quarter net profit of JPY727.9 billion, down 8% on-year, and for April-December, net profit dropped 18% to JPY1.90 trillion. Sales revenue rose 18% to JPY27.464 trillion from JPY23.267 trillion.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.